| Zazulina, Victoria (Boehringer 201908 Corporate VP + Global Head of Oncology Medicine) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Zbar, Brett (General Atlantic 202009– Managing Director + Global Head Life Sciences before Foresite Capital + Aisling) |
Managing Director |
General Atlantic (Group) |
United States (USA) |
| Zech, Birgit (Gotham Therapeutics 201708– COO before X-Rx + MAB Discovery + Pieris + Axxima) |
Business Development Manager / Strategy Manager |
Gotham Therapeutics (Group) |
Germany |
| Zechner, Rudolf (Univ Graz 201308 Professor at Instittue for Molecular Biosciences) |
Professor |
University of Graz (Karl-Franzens-Universität) |
Austria |
| Zehethofer, Karl |
n. a. |
Greiner (Group) |
Austria |
| Zehntner, Heiner (Endress+Hauser 201309 Member of Executive Board) |
Board member, executive |
Endress+Hauser (Group) |
Switzerland |
| Zeidler, Reinhard (Helmholtz 201801 Prof Gene Vectors Research Unit at Helmholtz Zentrum München) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Zeinali, Sirous (Genetek Biopharma 201805 Managing Director + Co-Founder) |
Managing Director |
Genetek Biopharma GmbH |
Germany |
| Zeise, Antje (Epigenomics 201112 Manager IR | PR) |
Public Relations Manager / Investor Relations Manager |
Epigenomics (Group) |
Germany |
| Zell, Andreas |
n. a. |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Zeller, Marco (VC Fonds Berlin 200508 Managing Director) |
Managing Director |
Berlin (govt region) |
Germany |
| Zeltner, Jürg (UBS 201604 President of UBS Wealth Management) |
President/Director/Head Business Group/Unit/Division |
UBS (Group) |
Switzerland |
| Zeltz, Patric (BadenBioTec 201104 Managing Director before BF-Biolabs 200312– founder) |
Managing Director |
BadenBioTec GmbH |
Germany |
| Zencke, Peter (MeVis Medical Solutions 200708–201106 Supervisory Board Member) |
Supervisory Board Member |
Varian Medical Systems (Group) |
Germany |
| Zenker, Matthias (GAIA 201702 Business Development) |
Business Development Manager / Strategy Manager |
GAIA AG |
Germany |
| Zenker, Othmar (InflaRx 201706– CMO before Head Clinical Research + Development since 2013 before CSL Behring) |
Research & Development Manager |
InflaRx (Group) |
Germany |
| Zenobi, Renato (ETH Zürich 201006 Professor Dept of Chemistry) |
Professor |
ETH Zürich (ETHZ) |
Switzerland |
| Zentgraf, Martin (Desitin 201202 General Manager of Desitin Arzneimittel GmbH) |
General Manager (management) |
Desitin Arzneimittel GmbH |
Germany |
| Zepp, Tobias (CRS Clinical Research Services 201706 Corporate Communications Manager) |
Public Relations Manager / Investor Relations Manager |
CRS Clinical Research Services (Group) |
Germany |
| Zerhouni, Elias A. (Sanofi-Aventis 201101– President Global RnD before NIH Director 2002–2008) |
Research & Development Manager |
Sanofi (Group) [since May 2011] |
France |
| Zerrer, Ralf (Clariant 201801 Head Strategic Marketing + Innovation at Business Unit Industrial + Consumer Specialties) |
Sales Manager / Marketing Manager |
Clariant (Group) |
Switzerland |
| Zettl, Rolf (Combinature co-founder + CEO 200011–200504 afterwards CBO) |
Chief Business Officer (CBO) |
MerLion (Group) |
Germany |
| Zettl, Rolf (Helmholtz 201502 Managing Director) |
Managing Director |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Zettl, Sophie (CEBINA 202003 before Arsanis + MedImmune/AZ) |
Business Development Manager / Strategy Manager |
CEBINA GmbH (Central European Biotech Incubator and Accelerator) |
Austria |
| Zettlmeissl, Gerd (Intercell 2005–201105 CEO before COO since 2001 before Chiron Behring before Behringwerke) |
Chief Executive Officer (CEO) |
Valneva (Group) |
Austria |
| Zetzmann-Krien, Diane (Bremen (govt) 201110 Managing Director of Bremer Aubau-Bank GmbH) |
Managing Director |
Bremen (govt region) |
Germany |
| Zeyer, Denis (Novalix 201011 CEO) |
Chief Executive Officer (CEO) |
Novalix (Group) |
France |
| Zeyfang, D. |
n. a. |
DaimlerChrylser (Group) |
Germany |
| Zhang, Ingrid (Novartis 201904 President Novartis Pharmaceuticals China) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
China |
| Zhang, Jay Z. (Shuwen Biotech 201512 CEO) |
Chief Executive Officer (CEO) |
Shuwen Biotech Co. Ltd. |
China |
| Zhang, Lei (Univ Bremen 200603) |
n. a. |
University of Bremen |
Germany |
| Zhang, Peizhuo (Qiagen 201305– General Manager of Qiagen (Suzhou) Translational Medical Center) |
General Manager (management) |
Qiagen (Group) |
China |
| Zhang, Weiyi (Boehringer 202007 Head of External Innovation Hub China) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
China |
| Zhang, Zeeman (Beijing Clear Biotech 201509 Director) |
President/Director/Head Business Group/Unit/Division |
Beijing Clear Biotech Co., Ltd. (BCB) |
China |
| Zheng, Li-Mou (Amoy Diagnostics 201607 CEO) |
Chief Executive Officer (CEO) |
Amoy Diagnostics Co., Ltd. (AmoyDx) |
China |
| Zhou, Jack (B&W Tek LLC 201807 CEO) |
Chief Executive Officer (CEO) |
Metrohm (Group) |
United States (USA) |
| Zhou, Li (TxCell 201610– VP Cell Engineerung before ZMKS + Novartis Biologics Center MA + MGH + Cereon Genomics) |
Researcher (industry) |
TxCell S.A. (Euronext Paris: TXCL) |
France |
| Zhu, Ted (Fosun Group 201407 General Manager of Fosun Diagnostics division) |
General Manager (management) |
Fosun (Group) |
China |
| Zhukovsky, Eugene (Biomunex 201510– CSO before Affimed + Boehringer Ingelheim Pharmaceuticals + Xencor) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Biomunex Pharmaceuticals SASU |
France |
| Ziebig, Marlene (Gulde Hengelhaupt Ziebig & Schneider 200809 Berlin) |
n. a. |
Grünecker, Kinkeldey, Stockmair & Schwanhäusser GbR |
Germany |
| Ziebolz, Burkhard (Roche Diagnostics 200503) |
n. a. |
Roche (Group) |
Germany |
| Ziegenhagen, Andreas (Dentons 201412 Managing Partner Germany) |
Managing Partner |
Dentons (Group) |
Switzerland |
| Ziegler, Andreas (Genetics Co 200106– CFO before Deloitte & Touche) |
Chief Financial Officer (CFO) |
Genetics Company Inc., The |
Switzerland |
| Ziegler, Michael (PVT Probenverteiltechnik GmbH 201103 Managing Director) |
Managing Director |
Roche (Group) |
Germany |
| Ziegler-Jöns, Alexander (Jacobs Uni 201311 Science + Technology Transfer + Vivace GmbH 201311 Managing Director) |
IP Manager |
Jacobs University Bremen gGmbH (JUB) |
Germany |
| Ziehr, Holger (Fraunhofer 201504 Head of Dept of Pharmaceutical Biotechnology at ITEM) |
Researcher (university / research institute) |
Fraunhofer (Group) |
Germany |
| Zienicke, Benjamim (BIOPRO Baden-Württemberg GmbH 201110– Project Manager Biotechnology) |
n. a. |
Baden-Württemberg (govt region) |
Germany |
| Zieziula, Gary (Merck (DE) 201601–201812 Head Biopharma North America joined 2014 before MSD + BMS + Roche LEFT 12/18) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
| Zilch, Christian Frank (Magna Diagnostics GmbH 201512 Managing Director) |
Managing Director |
|
|
| Zilian, Olav (Medigene 201601– SVP Corporate Development before Helvea SA + ISREC) |
Business Development Manager / Strategy Manager |
Medigene (Group) |
Germany |
| Zillikens, Stefanie (High-Tech Gründerfonds 201206 Marketing + Communciations Manager) |
Public Relations Manager / Investor Relations Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Zilliox, Patricia (Eyevensys 201712– CEO joined board 201605 before Foundation Fighting Blindness + Alcon) |
Chief Executive Officer (CEO) |
Eyevensys (Group) |
France |
| Zimmer, David (Coparion 201701 Managing Director) |
Managing Director |
Germany (govt) |
Germany |
| Zimmer, Franz-Josef (Grünecker, Kinkeldey, Stockmair & Schwanhäusser 200809 Munich) |
n. a. |
Grünecker, Kinkeldey, Stockmair & Schwanhäusser GbR |
Germany |
| Zimmer, Thomas (AMP Biosimilars 201505– Supervisory Board Chairman formerly at Boehringer Ingelheim) |
Supervisory Board Member |
AMP Biosimilars AG |
Germany |
| Zimmerman, Zachary A. (Forge Therapeutics 201612 CEO) |
Chief Executive Officer (CEO) |
Forge Therapeutics Inc. |
United States (USA) |
| Zimmermann, Bastian (Biaffin 201110 Managing Director) |
Managing Director |
Biaffin (Group) |
Germany |
| Zimmermann, Cyrill (Bellevue Group 201409 CEO of Adamant Biomedical Investments AG) |
Chief Executive Officer (CEO) |
Bellevue (Group) |
Switzerland |
| Zimmermann, Dirk (Biocartis 201905– Global Head Pharma Collaborations + Partnering before Roche Diagnostics + Qiagen) |
Business Development Manager / Strategy Manager |
Biocartis (Group) |
Belgium |
| Zimmermann, Elke |
n. a. |
Bremen (govt region) |
Germany |
| Zimmermann, Frank (Biomax Informatics 201710 Director Business Development) |
Business Development Manager / Strategy Manager |
Biomax (Group) |
Germany |
| Zimmermann, Heiko (Fraunhofer 201402 Head of Fraunhofer IBMT) |
President/Director/Head Business Group/Unit/Division |
Fraunhofer (Group) |
Germany |
| Zimmermann, Holger (AiCuris 201609 CEO before CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
STRÜNGMANN Group (family Strüngmann) |
Germany |
| Zimmermann, Jens (Adrenomed 2017– CMO before Vanda Pharmaceuticals + Roche + InterMune + Pfizer + Shire + Jerini) |
Chief Medical Officer (CMO) |
Adrenomed AG |
Germany |
| Zimmermann, Philip (Nebion 201801 CEO) |
Chief Executive Officer (CEO) |
Nebion AG |
Switzerland |
| Zimmermann, Ralf (Helmholtz-Zentrum München + Univ Rostock) |
Professor |
University of Rostock |
Germany |
| Zimmermann, Sabrina (BMG Labtech 201110 Sales Assistant BMG Labtech GmbH) |
Sales Manager / Marketing Manager |
BMG Labtech (Group) |
Germany |
| Zimmermann, Sven (Novimmune 201609– CFO before Auris Medical + PregLem + UBS Investment Bank) |
Chief Financial Officer (CFO) |
Novimmune S.A. |
Switzerland |
| Zinggrebe, Achim (Syneed Medidata GmbH 201305 Managing Director) |
Managing Director |
Syneed Medidata GmbH |
Germany |
| Zink, Barbara (Basilea 201109 Head Corporate Development) |
Business Development Manager / Strategy Manager |
Basilea (Group) |
Switzerland |
| Zinke, Holger (BRAIN 201507– Supervisory Board Member before CEO) |
Supervisory Board Member |
BRAIN (Group) |
Germany |
| Zinsser, Werner (Zinsser Analytic 200808 Managing Director) |
Managing Director |
Kohlberg Kravis Roberts (KKR) (Group) |
Germany |
| Zinsser-Noethen, Wiebke (Zinsser Analytic 200809) |
Sales Manager / Marketing Manager |
Kohlberg Kravis Roberts (KKR) (Group) |
Germany |
| Ziwica, Marcel (Zur Rose Group 202007 CFO) |
Chief Financial Officer (CFO) |
Zur Rose Group (Group) |
Switzerland |
| Zobel, Peter Hanns (Bayern (govt) 201606 Director at IZB) |
Managing Director |
Bavaria (govt region) |
Germany |
| Zohar, Daphne (PureTech Health 2016 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
PureTech Health (Group) |
United Kingdom (GB) |
| Zolghadr, Kourosh (ChromoTek 201403 Head of RnD) |
Research & Development Manager |
Proteintech (Group) |
Germany |
| Zollner, Stanislava (Helmholtz 202008 at Ascenion GmbH) |
Public Relations Manager / Investor Relations Manager |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Zoltobrocki, Manfred (PKCie 200604– Senior Consultant before Lux Biosciences GmbH + Epidaurus AG) |
Consultant (economic/technology) |
PKCie – Prof. Köpper & Cie Management Consultants GbR |
Germany |
| Zorbas, Haralabos (Bayern (govt) 201307 Managing Director of IBB Netzwerk GmbH) |
Managing Director |
Bavaria (govt region) |
Germany |
| Zoro, Barney (Sartorius 201803 ambr Product Manager at SSB) |
Product Manager (personnel) |
Sartorius (Group) |
Germany |
| Zsebo, Krisztina (Celladon Corp 201411 CEO) |
Chief Executive Officer (CEO) |
Celladon Corporation |
United States (USA) |
| Zuber, Johannes (IMP Vienna 2011– Group Leader + Quantro Therapeutics 202007 Co-Founder + Scientific Advisor) |
Researcher (university / research institute) |
Boehringer Ingelheim (Group) |
Austria |
| Zucchelli, Piero (Andrew Alliance 201806 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Waters (Group) |
Switzerland |
| Zucker, Maximilian (Numares 201702 Executive Board Member + Head RnD) |
Board member, executive |
Numares (Group) |
Germany |
| Zuliani, Vincent (GenoSafe 201611 Business Development Director) |
Business Development Manager / Strategy Manager |
GenoSafe S.A.S. |
France |
| Zumbansen, Markus (Ayoxxa 201407– VP RnD before Miltenyi Biotec) |
Research & Development Manager |
Ayoxxa (Group) |
Germany |
| Zumbrum, Michael (AllPure Technologies 201404 President) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
United States (USA) |
| zur Hausen, Harald |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| zur Hausen, Jan Dirk (Bergmann zur Hausen 201210 Managing Director + Co-founder) |
Managing Director |
Bergmann zur Hausen & Cie. GmbH |
Germany |
| Zurdo, Jesús (Rentschler 201911 SVP Innovation + Venture Partnerships) |
n. a. |
Rentschler (Group) |
Germany |
| Zurek Gabriela (Bruker Biosciences 2006 Bruker Daltonik GmbH Application Scientist) |
n. a. |
Bruker (Group) |
Germany |
| Zurlo, Alfredo (Glycotope 201604– CMO before Mologen 201304– CMO before Roche + EORTC) |
Chief Medical Officer (CMO) |
Glycotope (Group) |
Germany |
| Zwanziger, Ron (Alere/Inverness Medical 200603–201406 CEO RESIGNED 7/14) |
Chief Executive Officer (CEO) |
Alere (Group) |
United States (USA) |
| Zwick, Jordan (InflaRx 202009– promoted Chief Strategy Officer before BusDev + Corp Strategy before Salix + Medtronic) |
Business Development Manager / Strategy Manager |
InflaRx (Group) |
Netherlands |
| Zwicker, Jörk (ZSP Patentanwälte 201704 Partner beore Boehmert & Boehmert) |
Patent Attorney |
ZSP Patentanwälte (Zwicker Schnappauf & Partner Patentanwälte PartG mbB) |
Germany |
| Zündorf, Peter (Schering 2005– before Aventis Pharma before RPR + Bayer) |
n. a. |
Bayer (Group) |
Germany |
| Zünkeler, Martin (Kairos GmbH 201203 Managing Director) |
Managing Director |
Kairos GmbH |
Germany |
| Zypries, Brigitte (Germany (govt) 200809 Minister of Justice) |
Minister |
Germany (govt) |
Germany |
| Zywottek, Walter W. (Merck KGaA –200807 before VWR president and CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 73 74 75 
![Picture [iito] Männer Ballett 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-maenner-ballett.jpg)
![Picture [iito] Made Without Love 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-made-without-love.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
